SS Innovations Operating Income Over Time
| SSII Stock | 3.79 0.39 11.47% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out SS Innovations Performance and SS Innovations Correlation. Is there potential for Health Care Equipment & Supplies market expansion? Will SSII introduce new products? Factors like these will boost the valuation of SS Innovations. If investors know SSII will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about SS Innovations listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.06) | Revenue Per Share | Quarterly Revenue Growth 1.925 | Return On Assets | Return On Equity |
SS Innovations Inter's market price often diverges from its book value, the accounting figure shown on SSII's balance sheet. Smart investors calculate SS Innovations' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since SS Innovations' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between SS Innovations' value and its price as these two are different measures arrived at by different means. Investors typically determine if SS Innovations is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SS Innovations' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Income Analysis
Compare SS Innovations Inter and related stocks such as UFP Technologies, CONMED, and Establishment Labs Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UFPT | 1.3 M | 15.7 M | 16.7 M | 17.4 M | 11.6 M | 11.7 M | 12.2 M | 11.7 M | 19.6 M | 24.7 M | 16.7 M | 21.2 M | 55.4 M | 57.7 M | 80.9 M | 93 M | 97.7 M |
| CNMD | 1.4 M | 8.3 M | 65.2 M | 56.5 M | 52.8 M | 51.2 M | 37.7 M | 46.9 M | 71.3 M | 79.1 M | 46 M | 109.7 M | 70.1 M | 120.6 M | 200.3 M | 130.1 M | 136.6 M |
| ESTA | (360 K) | (360 K) | (360 K) | (360 K) | (360 K) | (360 K) | (15.8 M) | (20 M) | (23.9 M) | (30.9 M) | (27.9 M) | (25.1 M) | (39.7 M) | (65 M) | (50 M) | (45 M) | (47.2 M) |
| PRCT | (43.5 M) | (43.5 M) | (43.5 M) | (43.5 M) | (43.5 M) | (43.5 M) | (43.5 M) | (43.5 M) | (43.5 M) | (43.5 M) | (47.8 M) | (54.2 M) | (80.7 M) | (109.2 M) | (96.6 M) | (87 M) | (91.3 M) |
| SDGR | (19 M) | (19 M) | (19 M) | (19 M) | (19 M) | (19 M) | (19 M) | (19 M) | (28 M) | (38.7 M) | (60.9 M) | (111.4 M) | (146.8 M) | (177.4 M) | (209.3 M) | (188.4 M) | (178.9 M) |
| OMCL | (19.5 M) | 16.2 M | 27.1 M | 35.3 M | 49.6 M | 48.6 M | 6.5 M | 5.8 M | 44.4 M | 78.4 M | 35.5 M | 89.5 M | (2.3 M) | (34.9 M) | 337 K | 5.2 M | 4.9 M |
| OMDA | (72.3 M) | (72.3 M) | (72.3 M) | (72.3 M) | (72.3 M) | (72.3 M) | (72.3 M) | (72.3 M) | (72.3 M) | (72.3 M) | (72.3 M) | (72.3 M) | (72.3 M) | (66 M) | (43.7 M) | (50.2 M) | (52.7 M) |
| AHCO | 2.3 M | 2.3 M | 2.3 M | 2.3 M | 2.3 M | 2.3 M | 2.3 M | (690) | (1.2 M) | 29.4 M | 71.3 M | 225.6 M | 190.4 M | (598.4 M) | 263.7 M | 237.4 M | 249.2 M |
| TDOC | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (15.2 M) | (55.8 M) | (62.7 M) | (75.4 M) | (70.9 M) | (80.4 M) | (506.4 M) | (265.6 M) | (13.2 B) | (248.6 M) | (1 B) | (918.8 M) | (964.7 M) |
| PGNY | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (3.5 M) | 9.7 M | 8.3 M | 32.3 M | 23.3 M | 62.2 M | 67.5 M | 77.6 M | 81.5 M |
SS Innovations Inter and related stocks such as UFP Technologies, CONMED, and Establishment Labs Operating Income description
Operating Income is the amount of profit realized from SS Innovations Inter operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of SS Innovations International is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| SS Innovations International | SSII |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 405, iLabs Info |
| Exchange | NASDAQ Exchange |
null 3.79
Check out SS Innovations Performance and SS Innovations Correlation. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
SS Innovations technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.